 Your new post is loading...
Your new post is loading...
|
Scooped by
Ed Rybicki
August 21, 2020 9:47 AM
|
Pfizer and BioNTech have achieved success with their vaccine candidate against the coronavirus in an ongoing Phase 1 study in the United States.© Provided by Finanz.net Peter Bischoff/Getty Images…...
|
|
Scooped by
Ed Rybicki
August 20, 2020 11:01 AM
|
Interacting with reporters on the sidelines of the Independence Day celebrations at the Red Fort here, he also hailed the National Digital Health Mission unveiled by Prime Minister Narendra Modi in his address to the nation.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:59 AM
|
Late-stage biotech Novavax (NVAX) has announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 v...
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:58 AM
|
In the 38-second CGI video, Russian authorities have shown how the Sputnik V Vaccine emerges and slowly eradicates the virus which has engulfed the whole Earth.The clip is part of a press kit including photos, graphics and one other video showing the vaccine’s production...
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:57 AM
|
With China closing in on a coronavirus vaccine, Beijing’s top officials and some of its drugmakers have begun promising early access to countries of strategic interest as it seeks to shore up its global standing after a pandemic that has strained geopolitical ties.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:56 AM
|
Greece's health minister on Tuesday said he expects a first batch of COVID-19 vaccines in December under an EU deal for some three million doses overall.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:55 AM
|
ANALYSIS: The coronavirus pandemic appears, indirectly, to have actually saved lives in New Zealand.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:54 AM
|
The World Health Organization (WHO) on Tuesday reminded governments that instead of waiting and hoping for a vaccine against the new coronavirus to be available soon, they should continue to improve their response to contain spread of the COVID-19 contagion.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:52 AM
|
Kenya is participating in a randomised controlled clinical trials of TCZ and remdesivir.
|
|
Scooped by
Ed Rybicki
August 11, 2020 10:00 AM
|
Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:57 AM
|
Author summary Rotavirus is the leading cause of gastroenteritis in children worldwide. Effective rotavirus vaccines have been available for over a decade, but detailed understanding of the immune response to rotavirus infection is essential for further improvement of vaccines.
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:57 AM
|
There’s a lot in life that you can DIY – a bedside cabinet or shelves, for example – yet one we haven't heard before is assembling your own Covid-19 vaccin...
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:56 AM
|
Because two doses of the vaccine are needed to immunize people from COVID-19, total costs could be $74 per person....
|
|
|
Scooped by
Ed Rybicki
August 20, 2020 11:01 AM
|
Masks were controversial during 1918 pandemic t...
|
|
Scooped by
Ed Rybicki
August 20, 2020 11:00 AM
|
Chinese authorities have granted the first invention patent to a domestically developed COVID-19 vaccine candidate, which experts said demonstrates the vaccine's originality and creativity, and would enhance the international market's trust in China-developed COVID-19 vaccines amid the US'...
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:59 AM
|
As the number of people registered to take part in COVID-19 vaccine trials has now topped 100,000, we are encouraging others to follow their lead to help speed up efforts to discover safe and effective vaccines.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:58 AM
|
COVID-19 may have spread to the United States far earlier than we knew, researchers report. The first cases may have hit Seattle as early as last December.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:57 AM
|
A potential coronavirus vaccine being developed by a unit of China National Pharmaceutical Group (Sinopharm) could cost no more than 1,000 yuan ($144.27) for two shots, state media on Tuesday quoted chairman Liu Jingzhen as saying.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:56 AM
|
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:55 AM
|
Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the Australian Government and UK-based drug company AstraZeneca. Under the deal, every single Australian will be able to receive the University of Oxford COVID-19 vaccine for free, should trials prove successful, safe and effective. Prime Minister Scott Morrison said the Oxford University trial was in a phase three stage and more work was needed to prove its viability.
|
|
Scooped by
Ed Rybicki
August 20, 2020 10:53 AM
|
A major hypothesis holds that Christopher Columbus and his crew brought syphilis back to Europe. But new evidence suggests it was already there.
|
|
Scooped by
Ed Rybicki
August 11, 2020 10:00 AM
|
AstraZeneca has already reached deals with countries to make more than 2 billion doses of its Covid-19 vaccine, developed in partnership with the University of Oxford, and says it could be approved by the end of this year.
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:59 AM
|
A successful SARS-CoV-2 vaccine must be not only safe and protective but must also meet the demand on a global scale at low cost. Using the current influenza virus vaccine production capacity to manufacture an egg-based inactivated Newcastle disease virus (NDV)/SARS-CoV-2 vaccine would meet that challenge. Here, we report pre-clinical evaluations of an inactivated NDV chimera stably expressing the membrane-anchored form of the spike (NDV-S) as a potent COVID-19 vaccine in mice and hamsters. The inactivated NDV-S vaccine was immunogenic, inducing strong binding and/or neutralizing antibodies in both animal models. More importantly, the inactivated NDV-S vaccine protected animals from SARS-CoV-2 infections or significantly attenuated SARS-CoV-2 induced disease. In the presence of an adjuvant, antigen-sparing could be achieved, which would further reduce the cost while maintaining the protective efficacy of the vaccine.
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:57 AM
|
The news: Maryland biotechnology company Novavax has announced encouraging results from a preliminary study of its experimental coronavirus vaccine.The trial enrolled 131 healthy volunteers in Australia, gave them either a placebo or one of four escalating doses of its vaccine, and found that everyone...
|
|
Scooped by
Ed Rybicki
August 11, 2020 9:56 AM
|
NEW DELHI (AP) — Pygmy hogs — the world’s smallest and rarest wild pig — are under a virus lockdown. Not because of the coronavirus, but because of the first outbreak of African swine fever...
|
Scoop.it!
